Enimmune corporation (6564.TWO)
TWD 26.45
(-0.75%)
TWD 26.45
(-0.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -138.13 Million | -200.63 Million | -71.55 Million | -107.42 Million | -59.92 Million |
| Net Income | -237.69 Million | -267.08 Million | -47.24 Million | -74.45 Million | -56.64 Million |
| Depreciation & Amortization | 7.75 Million | 8.34 Million | 8.62 Million | 6.98 Million | 5.89 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 3.68 Million | 2.27 Million | - | 119 Thousand | 1.46 Million |
| Change in working capital | 87.89 Million | 51.12 Million | -33.01 Million | -40.08 Million | -10.65 Million |
| Other non-cash items | -960 Thousand | -974 Thousand | -2.16 Million | -1.5 Million | 22 Thousand |
| Investing Cash Flow | 87.85 Million | 99.93 Million | 90.1 Million | -286.83 Million | -40.03 Million |
| Investments in PPE | - | -347 Thousand | -3.4 Million | -4.51 Million | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | 123.49 Million | 93.5 Million | -281.4 Million | -40 Million |
| Sales/Maturities of investments | 88 Million | 123.49 Million | - | - | - |
| Other Investing Activities | -142 Thousand | -23.21 Million | 8000.00 | -923 Thousand | -40.03 Million |
| Financing Cash Flow | 16.03 Million | 381.07 Million | -3.93 Million | 375.65 Million | -942 Thousand |
| Debt repayment | -17.89 Million | -17.91 Million | -2.07 Million | -9.37 Million | -942 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 220.35 Million | - | 367.94 Million | - |
| Other Financing Activities | 20 Million | 144.67 Million | - | 367.94 Million | - |
| Accounts receivables | -7.47 Million | 17.45 Million | 1.19 Million | -22.92 Million | -321 Thousand |
| Accounts payables | 14.09 Million | - | - | - | - |
| Inventory | 44.77 Million | -8.47 Million | -9.79 Million | -42.05 Million | -158 Thousand |
| Other working capital | 36.5 Million | 48.53 Million | -19.38 Million | 7.78 Million | -10.17 Million |
| Cash at beginning of period | 394.17 Million | 118.38 Million | 103.77 Million | 122.37 Million | 223.26 Million |
| Cash at end of period | 359.89 Million | 394.17 Million | 118.38 Million | 103.77 Million | 122.37 Million |
| Capital Expenditure | - | -347 Thousand | -3.4 Million | -4.51 Million | - |
| Effect of forex changes on cash | -38 Thousand | -4.58 Million | - | - | - |
| Net cash flow / Change in cash | -34.28 Million | 275.78 Million | 14.61 Million | -18.6 Million | -100.89 Million |
| Free Cash Flow | -138.13 Million | -200.98 Million | -74.95 Million | -111.93 Million | -59.92 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -39.64 Million | -42.64 Million | -237.69 Million | -73.01 Million | -73.01 Million | -38.85 Million |
| Depreciation & Amortization | 1.89 Million | 1.89 Million | 7.75 Million | 1.84 Million | 1.84 Million | 1.95 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.55 Million | - | 3.68 Million | 652.5 Thousand | 652.5 Thousand | 1.19 Million |
| Change in working capital | 3.74 Million | 3.74 Million | 87.89 Million | 29.23 Million | 29.23 Million | 7.67 Million |
| Other non-cash items | -6.53 Million | -1.97 Million | -960 Thousand | 5.99 Million | 5.99 Million | -5.73 Million |
| Investing Cash Flow | -19.74 Million | -19.74 Million | 87.85 Million | 43.95 Million | 43.95 Million | -26 Thousand |
| Investments in PPE | -192.5 Thousand | -192.5 Thousand | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 88 Million | - | - | - |
| Other Investing Activities | -19.55 Million | -19.55 Million | -142 Thousand | 43.95 Million | 43.95 Million | -26 Thousand |
| Financing Cash Flow | 128.99 Million | 128.99 Million | 16.03 Million | -993 Thousand | -993 Thousand | 9 Million |
| Debt repayment | - | - | -17.89 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 128.99 Million | 128.99 Million | 20 Million | -993 Thousand | -993 Thousand | 9 Million |
| Accounts receivables | -3.05 Million | -3.05 Million | -7.47 Million | -3.52 Million | -3.52 Million | -214 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 2.58 Million | 2.58 Million | 44.77 Million | 18.87 Million | 18.87 Million | 3.51 Million |
| Other working capital | 4.21 Million | 4.21 Million | 36.5 Million | 13.87 Million | 13.87 Million | 4.37 Million |
| Cash at beginning of period | - | - | 394.17 Million | - | - | - |
| Cash at end of period | 73.83 Million | 73.83 Million | 359.89 Million | 6.85 Million | 6.85 Million | -23.99 Million |
| Capital Expenditure | -192.5 Thousand | -192.5 Thousand | - | - | - | - |
| Effect of forex changes on cash | 3.55 Million | 3.55 Million | -38 Thousand | -821 Thousand | -821 Thousand | 802 Thousand |
| Net cash flow / Change in cash | 73.83 Million | 73.83 Million | -34.28 Million | 6.85 Million | 6.85 Million | -23.99 Million |
| Free Cash Flow | -39.16 Million | -39.16 Million | -138.13 Million | -35.28 Million | -35.28 Million | -33.77 Million |
RAJOOENG
CPT
IDEA
ED
LYV
ALCRB